Midecamycin 是乙酰氧基取代的大环内酯类抗生素，对革兰氏阳性和阴性菌有效。

Midecamycin, an acetoxy-substituted macrolide antibiotic, has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.

Midecamycin inhibits the majority of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations of less than 3.1 μg/mL [1]. Midecamycin is a novel 16-membered macrolide antibiotic, which is produced by Streptomyces mycarofaciens [2].

35457-80-8

C41H67NO15

813.979

Antibiotic SF-837;Platenomycin B1;Rubimycin;Turimycin P3;Espinomycin A;Medecamycin A1;麦迪霉素

Ethanol:50 mg/mL
DMSO:50 mg/mL
H2O:Insoluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years